Canadá - inglês - Health Canada

pfizer canada ulc - ethynodiol diacetate; ethinyl estradiol - tablet - 2mg; 30mcg - ethynodiol diacetate 2mg; ethinyl estradiol 30mcg - contraceptives

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pharmacia ireland - etynodiol diacetate - tablets - 0.5mg milligram

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

g.d. searle & company limited - ethinylestradiol etynodiol diacetate - tablets

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

g.d. searle & company limited - mestranol etynodiol diacetate - tablets

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

g.d. searle & company limited - ethinylestradiol etynodiol diacetate - tablets

Israel - inglês - Ministry of Health

tec-o-pharm-libra ltd - chlormadinone acetate; ethinylestradiol - film coated tablets - ethinylestradiol 0.03 mg; chlormadinone acetate 2 mg - etynodiol and estrogen - etynodiol and estrogen - oral hormonal contraceptive.

Estados Unidos - inglês - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - ethynodiol diacetate (unii: 62h10a1236) (ethynodiol - unii:9e01c36a9s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - ethynodiol diacetate 1 mg - kelnor 1/50 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptive products such as kelnor 1/50, which contain 50 mcg of estrogen, should not be used unless medically indicated. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and progestogen implants and injections, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing % of women an unintended pregnancy continuing within the first year of use use at one year(c) method typical use(a) perfect use(b) (1) (2) (3) (4) chance(d) 85 85 spermicides(e) 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal(f) 2 post-ovulation 1 withdrawal 19 4 cap(g) parous women 40 26 42 n

Estados Unidos - inglês - NLM (National Library of Medicine)

manchester pharmaceuticals inc. - chenodiol (unii: 0gei24lg0j) (chenodiol - unii:0gei24lg0j) - chenodiol 250 mg - chenodal (chenodiol tablets) is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. the likelihood of successful dissolution is far greater if the stones are floatable or small. for patients with nonfloatable stones, dissolution is less likely and added weight should be given to the risk that more emergent surgery might result form a delay due to unsuccessful treatment. safety of use beyond 24 months is not established. chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.

Estados Unidos - inglês - NLM (National Library of Medicine)

actavis pharma, inc. - ethynodiol diacetate (unii: 62h10a1236) (ethynodiol - unii:9e01c36a9s) - ethynodiol diacetate 1 mg

Estados Unidos - inglês - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - ethynodiol diacetate (unii: 62h10a1236) (ethynodiol - unii:9e01c36a9s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - zovia 1/35 (28 day regimen) (ethynodiol diacetate and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and progestogen implants and injections, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year *  method (1) typical use † (2) perfect use ‡ (3) (4) chance§ 85 85 spermicides¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal# 2 post-ovulation 1 withdrawal 19 4 capÞ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous w